NEW YORK (GenomeWeb) — Tataa Biocenter has signed a deal to distribute and support Yikon Genomics' MALBAC single-cell whole-genome amplification products in Sweden, Norway, Germany, Austria, Slovakia , and the Czech Republic, the partners announced today. 

As part of the arrangement, Gothenburg, Sweden-based Tataa will also use the MALBAC technology in its next-generation sequencing training courses. Additional terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.